Alnylam Pharmaceuticals Inc (ALNY)
NASDAQ · Healthcare
Alnylam Pharmaceuticals Inc Total Liabilities 2008–2025
Alnylam Pharmaceuticals Inc annual total liabilities history from 2009 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Alnylam Pharmaceuticals Inc total liabilities as of December 31, 2025: 4.18B, a 0.10% increase year-over-year.
- Alnylam Pharmaceuticals Inc total liabilities for 2025 were 4.18B, a 0.10% increase from 2024.
- Alnylam Pharmaceuticals Inc total liabilities for 2024 were 4.17B, a 3.02% increase from 2023.
- Alnylam Pharmaceuticals Inc total liabilities for 2023 were 4.05B, a 9.34% increase from 2022.
- Alnylam Pharmaceuticals Inc total liabilities for 2022 were 3.70B.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Alnylam Pharmaceuticals Inc Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $4,177 |
| 2024 | $4,173 |
| 2023 | $4,051 |
| 2022 | $3,705 |
| 2021 | $3,055 |
| 2020 | $2,391 |
| 2019 | $956 |
| 2018 | $273 |
| 2017 | $228 |
| 2016 | $343 |
| 2010 | $235 |
| 2009 | $303 |
Alnylam Pharmaceuticals Inc Total Liabilities — FAQ
Alnylam Pharmaceuticals Inc (ALNY) total liabilities over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ALNY's total liabilities history?
The chart and table above show Alnylam Pharmaceuticals Inc's total liabilities by year and by quarter, including the growth rate.